Vanguard Group Inc Lexicon Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,401,225 shares of LXRX stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,401,225

Previous 5,980,371 7.04%

Holding current value

$10.8 Million

Previous $9.15 Million 67.91%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.3 - $3.58 $547,110 - $1.51 Million	420,854 Added 7.04%	6,401,225 $15.4 Million
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.53 $419,840 - $642,355	-419,840 Reduced 6.56%	5,980,371 $9.15 Million
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $60,145 - $132,206	-56,741 Reduced 0.88%	6,400,211 $6.98 Million
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $2.49 Million - $4.04 Million	1,157,572 Added 21.84%	6,456,952 $14.8 Million
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $85,633 - $115,325	43,032 Added 0.82%	5,299,380 $12.9 Million

Q4 2022 Feb 10, 2023	BUY	$1.8 - $2.56 $108 - $153	60 Added 0.0%	5,256,348 $10 Million
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $2.59 Million - $4.58 Million	1,334,318 Added 34.02%	5,256,288 $12.6 Million
Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $306,888 - $630,175	-234,266 Reduced 5.64%	3,921,970 $7.3 Million
Q1 2022 May 13, 2022	BUY	$1.95 - $3.89 $8,743 - $17,442	4,484 Added 0.11%	4,156,236 $8.69 Million
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $634,639 - $1.03 Million	166,572 Added 4.18%	4,151,752 $16.4 Million
Q3 2021 Nov 12, 2021	BUY	$3.38 - $5.35 $51,345 - $81,271	15,191 Added 0.38%	3,985,180 $19.2 Million
Q2 2021 Aug 13, 2021	BUY	$4.12 - $5.87 $16.4 Million - $23.3 Million	3,969,989 New	3,969,989 $18.2 Million

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $317M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Lexicon Pharmaceuticals, Inc. Transaction History